Cotton-McCaskill PACED Act Would Help Patients Gain Access to More Affordable Generics
The bipartisan PACED Act would stop Allergan’s patent abuse
Brand pharmaceutical companies are finding new, innovative ways to avoid competition from generic and biosimilar medicines, extend their government-provided monopolies and keep patients paying high drug prices. Look no further than Allergan.